Company Filing History:
1 out of 4 
1 out of 1,187 
Years Active: 2020
Title: Todd Kinsella: Innovator in Protein Engineering
Introduction
Todd Kinsella is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of protein engineering, particularly through his innovative patent related to cereblon proteins. His work has implications for various applications in biotechnology and medicine.
Latest Patents
Todd Kinsella holds a patent for an in vivo engineered cereblon protein. This patent discloses methods for creating a modified cereblon protein that includes site-specific non-naturally occurring modifications at cysteine 287 or cysteine 286. The modifications result from an in vivo Michael addition reaction between an exogenous Michael acceptor and the specified cysteine residues. This innovative approach has the potential to advance therapeutic strategies involving cereblon proteins.
Career Highlights
Throughout his career, Todd has worked with notable organizations such as Vividion Therapeutics, Inc. and The Scripps Research Institute. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Todd Kinsella has collaborated with esteemed colleagues, including David S. Weinstein and Benjamin F. Cravatt. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in advancing their collective research efforts.
Conclusion
Todd Kinsella is a distinguished inventor whose work in protein engineering has the potential to impact various scientific fields. His innovative patent and collaborations highlight his commitment to advancing biotechnology.